Â¥
5.58
Sep 30
New Key Statistics Module, Z-Score and F-Score
SZSE:300239 Key Ratios
Market Cap ¥ M | 3,312.31 |
Enterprise Value ¥ M | 2,985.96 |
P/E(ttm) | 33.82 |
PE Ratio without NRI | 32.63 |
Forward PE Ratio | -- |
Price/Book | 1.95 |
Price/Sales | 3.98 |
Price/Free Cash Flow | 29.05 |
Price/Owner Earnings | 232.49 |
Payout Ratio % | 0.13 |
Revenue (TTM) ¥ M | 898.00 |
EPS (TTM) ¥ | 0.17 |
Beneish M-Score | -3.37 |
10-y EBITDA Growth Rate % | 13.00 |
5-y EBITDA Growth Rate % | 22.60 |
y-y EBITDA Growth Rate % | -17.70 |
EV-to-EBIT | 20.40 |
EV-to-EBITDA | 20.40 |
PEG | 1.44 |
Shares Outstanding M | 593.60 |
Net Margin (%) | 11.83 |
Operating Margin % | 14.46 |
Pre-tax Margin (%) | 14.06 |
Quick Ratio | 3.38 |
Current Ratio | 4.44 |
ROA % (ttm) | 3.99 |
ROE % (ttm) | 6.43 |
ROIC % (ttm) | 6.43 |
Dividend Yield % | 0.39 |
Altman Z-Score | 3.15 |
SZSE:300239 Number of Guru Trades
SZSE:300239 Volume of Guru Trades
Gurus Latest Trades with SZSE:300239
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300239 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Baotou Dongbao Bio-Tech Co Ltd Insider Transactions
No Available Data